Quest Diagnostics Q2 Profit Decreases, but beats estimates

Quest Diagnostics (DGX) reported a profit for second quarter that decreased from last year but beat the Street estimates.

The company's earnings totaled $234 million, or $1.96 per share. This compares with $631 million, or $4.96 per share, in last year's second quarter.

Excluding items, Quest Diagnostics reported adjusted earnings of $281 million or $2.36 per share for the period.

Analysts on average had expected the company to earn $2.30 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 3.9% to $2.45 billion from $2.55 billion last year.

Quest Diagnostics earnings at a glance (GAAP) :

-Earnings (Q2): $234 Mln. vs. $631 Mln. last year.
-EPS (Q2): $1.96 vs. $4.96 last year.
-Analyst Estimates: $2.30
-Revenue (Q2): $2.45 Bln vs. $2.55 Bln last year.

Full year EPS guidance: $9.55 - $9.95
Full year revenue guidance: $9.50 - $9.75 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT